Updated Jul 16, 2026
OBOYLE KEVIN C has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.

Kevin C. Oboyle is a corporate insider known for his role as a Director at multiple medical technology companies, including Carlsmed, Inc. and iRhythm Technologies, Inc. He has participated in SEC filings related to these companies, indicating his involvement in corporate governance.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | CARL | CARLSMED, INC. | A — Grant or award | 13.7K | $0.00 | |
| 2026-06-05 | OM | Outset Medical, Inc. | A — Grant or award | 10.7K | $0.00 | |
| 2026-05-29 | IRTC | iRhythm Holdings, Inc. | A — Grant or award | 1.6K | $0.00 | |
| 2025-07-22 | CARL | CARLSMED, INC. | A — Grant or award | 17.3K | $0.00 | |
| 2025-07-07 | IRTC | iRhythm Holdings, Inc. | A — Grant or award | 2.0K | $0.00 | |
| 2025-06-02 | OM | Outset Medical, Inc. | A — Grant or award | 9.0K | $0.00 | |
| 2025-05-14 | OM | Outset Medical, Inc. | A — Grant or award | 15.1K | $0.00 | |
| 2025-04-03 | NVRO | NEVRO CORP | D — Derivative transaction | 43.4K | — |
Kevin C. Oboyle is a corporate insider known for his role as a Director at multiple medical technology companies, including Carlsmed, Inc. and iRhythm Technologies, Inc. He has participated in SEC filings related to these companies, indicating his involvement in corporate governance.…
3 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live OBOYLE KEVIN C profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.